The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Oncolytics
Stock and Other Ownership Interests - Oncolytics
A study of pelareorep in combination with pembrolizumab and chemotherapy in patients (pts) with relapsed metastatic adenocarcinoma of the pancreas (MAP).
 
Devalingam Mahalingam
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; EMD Serono; Genentech
Consulting or Advisory Role - Amgen; Baxalta/Shire; Bristol-Myers Squibb
Speakers' Bureau - Amgen; Bayer; Genentech
Research Funding - Merck
 
Christos Fountzilas
No Relationships to Disclose
 
Jennifer L. Moseley
No Relationships to Disclose
 
Nicole Noronha
Employment - Oncolytics
Stock and Other Ownership Interests - Oncolytics
 
Karol Cheetham
Employment - Oncolytics
Stock and Other Ownership Interests - Oncolytics
 
Adrian Dzugalo
Employment - Oncolytics
Stock and Other Ownership Interests - Oncolytics
 
Gerard Nuovo
Consulting or Advisory Role - Oncolytics
Research Funding - Oncolytics
 
Andres Gutierrez
No Relationships to Disclose
 
Sukeshi Patel Arora
No Relationships to Disclose